IFNB1 and neoplasm: On days 19 and 26, we intratumorally injected human IFN-β (5000 U/shot) into the mice because type I IFNs not only upregulate PD-L1 molecules but also induce T cell-recruiting chemokines in both immune cells and tumor cells [36].